Study comparing Zenagamtide and Semaglutide for weight loss
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new medicine Zenagamtide to see if it helps people with excess weight lose more weight than Semaglutide, an existing weight loss drug. You may join if you are an adult with overweight or obesity but do not have diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have excess body weight (your doctor can confirm)
- You do not have type 1 or type 2 diabetes
- Your blood sugar level (HbA1c) is below 6.5% at the screening test
- You have not taken any GLP-1 medicines (like Ozempic or Wegovy) or similar drugs in the past year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called zenagamtide for adults with overweight or obesity, with or without type 2 diabetes, who are currently taking semaglutide. The goal is to see how well people tolerate switching from semaglutide to the new treatment.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study is testing a new tablet called Zenagamtide to help people with extra body weight lose weight. It's for adults who are not diabetic and haven't used similar weight loss drugs before.
This trial tests a medicine called semaglutide (often used for diabetes) to see if it helps people in Bangladesh who are overweight or obese lose weight. The study will check if the medicine is safe and effective for both people with and without type 2 diabetes.
This study tests an investigational medicine called Zenagamtide to see if it helps people with excess body weight lose weight. It is specifically for adults in Asia who do not have diabetes and have not taken certain weight-loss or diabetes medicines before.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.